TABITHA HUMPHREY: Open Payments
NPI 1467070623 · HARRODSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 41 payments from 17 companies in 2025. Trend: 2023 $299 · 2024 $587 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Novo Nordisk Inc | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $48 |
| Dexcom, Inc. | 1 | $38 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Corium, LLC | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, Jornay PM, QULIPTA, Dexcom G6 Transmitter, Wegovy, FANAPT, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
